Drug Trial Radar · NCT00240747
Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
Last checked: Nov 19, 2026Latest source record: May 25, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
Not stated
Start
Jun 2000
Primary completion
Not stated
Study completion Jan 2005
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- Collaborators
- Aventis Pharmaceuticals
- First posted
- Oct 18, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 27 weeks, up to 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Open-label, multicenter, multiple-dose, study of population pharmacokinetics of I.V. Synercid (7.5 mg/kg every 8 hours) in 75 pediatric patients. The purpose is to assess the population pharmacokinetics of Synercid in pediatric patients and to collect additional safety and efficacy data in pediatric patients.
Conditions
- Gram-Positive Bacterial Infections
Interventions
SynercidDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Population pharmacokinetics
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Children's Hospital
Oakland, California
Children's Hospital of Orange County
Orange, California
Duke University Medical Center
Durham, North Carolina
Children's Hospital
Cincinnati, Ohio
The Cleveland Clinic
Cleveland, Ohio
Children's Hospital at Saint Francis
Tulsa, Oklahoma
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.